Triple-negative breast cancer: current treatment strategies and factors of negative prognosis

Breast cancer is the most common cancer in women and the most common cause of death in working-age women. According to the results of immunohistochemical studies, 10-20% of cases revealed a triple-negative type of breast cancer. This subtype is characterized by significant proliferative activity and...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of medicine and life Vol. 15; no. 2; pp. 153 - 161
Main Authors:	Baranova, Anna, Krasnoselskyi, Mykola, Starikov, Volodymyr, Kartashov, Sergii, Zhulkevych, Igor, Vlasenko, Vadym, Oleshko, Kateryna, Bilodid, Olga, Sadchikova, Marina, Vinnyk, Yurii
Format:	Journal Article
Language:	English
Published:	Romania Carol Daila University Foundation 01-02-2022 Carol Davila University Press
Subjects:	Androgens Breast cancer Breast Neoplasms - pathology Cancer therapies Chemotherapy Epidermal growth factor Estrogens Female Gene expression Humans Lymphatic system Mastectomy Medical prognosis Metastasis Neoadjuvant Therapy - methods Prognosis Quality of Life Radiation therapy Radicalism Review Surgery Triple Negative Breast Neoplasms - drug therapy Triple Negative Breast Neoplasms - surgery Womens health IHC – immunohistochemical CT– chemotherapy breast cancer surgical treatment late result triple-negative type ART – adjuvant radiation therapy NACT – neoadjuvant chemotherapy radical mastectomy ER – estrogen receptors LN – lymph node TNBC – triple-negative breast cancer organ-preserving operations ACT – adjuvant chemotherapy AR – androgen receptors BC – breast cancer RM – radical mastectomy BMI – body mass index
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Breast cancer is the most common cancer in women and the most common cause of death in working-age women. According to the results of immunohistochemical studies, 10-20% of cases revealed a triple-negative type of breast cancer. This subtype is characterized by significant proliferative activity and growth rate, aggressive clinical course, and early metastasis. This leads to a suspicious prognosis and, accordingly, encourages an increase of surgical treatment radicalism and aggressive systemic treatment. This review briefly analyzes existing treatment strategies for triple-negative breast cancer with a focus on surgical treatment. Surgical treatment is an integral part of complex therapy. Currently, the attention of researchers is focused not only on the radicalism of the operation, ensuring long-term survival, but also on achieving a good cosmetic result that determines the quality of life of patients. In this aspect, organ-preserving and prosthetic methods of operations are promising, the feasibility and effectiveness of which are being discussed. The relevance of choosing the optimal method of operation is evidenced by the lack of generally accepted approaches based on informative markers for the prognosis of the course of the disease. Therefore, the choice of the optimal method of surgical treatment taking into account the individual characteristics of the patient and the tumor, indications for chemotherapy, and radiation therapy remains an unresolved issue and requires further research.
ISSN:	1844-122X 1844-3117
DOI:	10.25122/jml-2021-0108